- Home
- MBIN vs OCUL Comparison
MBIN vs OCUL Comparison
Compare MBIN & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBIN | OCUL |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MBIN | OCUL |
|---|---|---|
| Price | $52.81 | $10.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $43.67 | $23.56 |
| AVG Volume (30 Days) | 118.9K | ★ 2.7M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.73 | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $31.76 | $7.93 |
| Revenue Next Year | $3.73 | $96.07 |
| P/E Ratio | $19.22 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $30.37 | $6.23 |
| 52 Week High | $56.87 | $16.44 |
Technical Indicators
Market Signals| Indicator | MBIN | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 47.83 | 52.72 |
| Support Level | $45.39 | $10.05 |
| Resistance Level | $54.48 | $10.78 |
| Average True Range (ATR) | 1.33 | 0.50 |
| MACD | -0.24 | -0.03 |
| Stochastic Oscillator | 32.29 | 38.60 |
Price Performance
Historical ComparisonAbout MBIN Merchants Bancorp
Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.